Abstract
DATE: |
November 5, 2009 |
TIME: |
1:15 - 3:00 pm |
LOCATION: |
Center for Clinical Sciences Research (CCSR), Rm 4205 |
TITLE: |
Vaccine-Induced Immunity to Influenza |
SPEAKER: |
David B. Lewis, M.D., Professor of Pediatrics at the Lucile Salter Packard Children's Hospital |
I will present pre-clinical studies in which cationic lipid DNA complexes (CLDC), a novel adjuvant, is being developed for use in an inactivated influenza vaccine. I will also outline proposed studies in humans in an ongoing phase II trial of CLDC that aim to predict vaccine immunogenicity.
Internal Staff Login